Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Luton

Protein Purification and Biophysical Characterisation 2025

Protein purification and biophysical characterisation are essential techniques in both academic and industrial biochemistry. This hands-on training course at the University of Bedfordshire’s STEM Building [...]

Edinburgh

Translation UK 2025

The 30th Translation UK meeting will highlight the latest advancements across the broad and dynamic UK mRNA translation research community. Spanning all kingdoms of life, [...]

Go to Top